Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "- 108 -"

Transcription

1 3-107-

2

3 LD50 LC50 ATE (mg kg ) a (mg kg ) a (ppm) a b mg a b c d (mg ) a b e f ppmv (a) (ATE) - LD50/LC

4 (b) (c) (d) 1(100ppm) 2(500ppm) 3(2500ppm) 4(5000ppm) ppm : ( ) ; : ( ) ; : 1µm 100µm (e) OECD (f) 5 LD mg kg 5 (i) LD50 (LC50) 5 5 (ii)

5 IOMC CG HCCS LD LD mg kg mg ppm mg ppmv OECD (MMAD) mg/l OECD mg/kg (f)

6 in vitro % %

7 (a) (b) (ATE) (Conversion Value) (mg/kg ) (mg/kg ) (ppmv) (mg/ ) l (mg/ ) ppm mg/kg LD

8 ATE 1/ (Bridging principles) LD mg/kg LD mg/kg A B C A B C A B

9 (a) 2 ( ) A+B ( ) C+B (b) B (c) ( ) A ( ) C (d) A C A C B ( ) (ATE) (a) (b) (c) GHS 2,000mg/kg (ATE) ATE ATE Ci = i i ATEmix = Ci ATEi ATEi= i

10 ATE (a) 2 (b) (c) (d) % x % % % 100 ( C unknown if > 10%) ATEmix = Ci ATEi

11 : : : LD50 5 mg/kg LD mg/kg ( ) LC ppm ( ) LC mg/l ( ) LC mg/l LD 50 >5 <50 mg/kg LD 50 >50 < 200 mg/kg ( ) LC 50 >100 < 500 ppm ( ) LC 50 > 0.5 < 2.0 mg/l ( ) LC 50 > mg/l

12

13 LD 50 >50 < 300 mg/kg LD 50 > 200 < 1000 mg/kg ( ) LC 50 >500 < 2500 ppm ( ) LC 50 >2 < 10.0 mg/l ( ) LC 50 >0.5 < 1.0 mg/l LD 50 >300 < 2000 mg/kg LD 50 >1000 < 2000 mg/kg ( ) LC 50 >2500 < 5000 ppm ( ) LC 50 >10 < 20 mg/l ( ) LC 50 >1 < 5 mg/l LD 50 >2000 < 5000 mg/kg LD 50 >2000 < 5000 mg/kg ( ) LC 50 LD 50 ( mg/kg )

14 ( )

15 3.1.2 ( ) i = ATE mix n Ci= i C ATE i ATE mix n i n ATEi = i 3 ( ATE mix 10 ) ( C unknown if > 10% ) = ATEmix n Ci ATEi

16

17 ( ) ph in vitro in vivo ph

18 a g) a) 1b g) a) 1c 2a b) a) 2b b) a) 3 ph c) ph a) ph 4 d) 5 in vitro e a)

19 in vitro f a) 7 in vitro ( 1 ) a) 8 In vivo 3 h) a) 9 a) g (a) (b) (c) ph (d) in vivo (e) in vitro OECD (f) in vitro (g) OECD (h)

20 ( ) 3 1A 3 1 1B C a 3 1 ( ( ) ) 1A 3 1 1B C a (a) (b) (c) ( ) ( )

21 a (1) ( 2) 72 ( ) (2) 2 14 (3) ( 3) 3 ( ) a

22 ph ph in vitro (Bridging principle) A B C A B C A B

23 (a) 2 ( ) A+B ( ) C+B (b) B (c) ( ) A ( ) C (d) A C A C B ( ) ph %

24 3% % 3% ( ) 5% 5% 1% 10% 10% 1% 10% (10 ) (10 ) 10% 10% 1% 10% 5% 5% 5% 5%

25 3.2.4 ph 2 1% ph % 1% 3% A 1 B 1 C

26 ( 3.2.1, ) In vitro ph ( )

27 (3.2.1, ) In vitro ( )

28 3.2.2 ( ) 4,5 (3.2.1, ) ph ,5 ( )

29 7 5 5% 5 1% < 5% 10% (10 ) + 10% 5 1% < 10% 10% (10 ) + 1% < 10% (10 ) %

30

31 (SAR) (SPR) in vitro in vivo ph ph in vitro in vivo ph

32 Solna a 1b 2 OECD(1996) ENV/MC/TG(96)9(http:www.oecd.ehs/background.htm)

33 c 2a 2b 2c 3a 3b ph ph 11.5 ph 2 2 ph

34 in vitro 5a in vitro in vitro 6 in vitro in vitro 7 6a In vitro

35 a b 1a - (ii) 1b - 1 2a b c SAR SPR SAR SPR SAR SPR (i) 2a - - (ii) 2c ph 1 4 LD in vitro in vivo

36 Draize (c)

37 ph ph in vitro (Bridging principle)

38 A B C A B C A B (a) 2 ( ) A+B ( ) C+B (b) B (c) ( ) A ( ) C (d) A C ( )

39 ph % 3% % 3% % 3% 1% 10% (10 ) 10% 3% 3% 1% 10 10%

40 3.3.4 ph 2 1% ph % 1% 3% A 2B

41 ( ) 4 In vitro ph

42 In vitro ( )

43 3.3.2 ( ) ( ) ph < 2 > ( ) < 1 %,

44 7 3% 3% 7 1% < 3% 2/2A 10% (10 ) + 2A/2B 10% 1 + 1% < 3% 10 ( 1 + 1) + 2A/2B 10%

45 (a) (b) (a) (i) in vivo (ii) in vitro

46 (iii) (iv) (b) (a) E (IgE) (b) (a) 2 maximisation test

47 (b) (c) (d) (e) (a) (b) (c) (d) (e) % 15% OECD 406 Maximisation Test Buehler

48 OECD (Bridging principle)

49 (a) 2 ( ) A+B ( ) C+B (b) B (c) ( ) A ( ) C (d) B A C (e) A C B ( ) % 1 1.0% 2 0.1% 3 0.1% 5 1.0% 4 0.2% SDS

50 1.0 SDS SDS SDS SDS SDS

51 : : % w/w 0.2% v/v

52 % w/w 1% v/v

53 in vitro in vivo DNA DNA DNA DNA DNA In vitro OECD in vivo (OECD478) (OECD485) in vivo (OECD475) (OECD484) (OECD474)

54 in vivo - in vivo in vivo - in vitro - in vivo - in vitro in vivo - in vitro in vivo (a) (OECD483) (b) (SCE) DNA (UDS) in vivo DNA (UDS) (OECD486) (SCE)

55 In vitro (OECD473) (OECD476) (OECD471) (Bridging principle) (a) 2 ( ) A+B ( ) C+B (b) B

56 (c) ( ) A ( ) C (d) A C A C ( ) % % A 1B

57 GHS

58 % 1.0%

59 in vivo

60

61 ( )

62 (IARC) (a) (b) (c ) (d) (e) (f) (g) (h) (i) (j) (k)

63 in vivo WHO IPCS 1995,Carshalton,UK (Bridging principle)

64 (a) 2 ( ) A+B ( ) C+B (b) B (c) ( ) A ( ) C (d) A C A C B ( ) % % 1 1.0%

65 % 1% SDS 0.1% 1% 2 2 1% SDS A 1B

66

67 , , % 2 0.1% 2 1.0%

68 International Agency for Research on Cancer IARC (a) (b) (a) (b) (c) (i) (ii)1 (i) (ii) (iii) IARC OECD OECD

69 IPCS/EHC (a) (b) / (a) (b) (c) (d)

70 (a)

71 3.7.1(b) (a) (b) (c) B

72

73 %

74 OECD 414 ICH S5A 1993 ICH S5B 1995 OECD OECD In vitro (SAR) OECD

75 OECD 1000mg kg (Bridging principle) (a) 2 ( ) A+B ( ) C+B (b) B (c) ( ) A ( ) C

76 (d) A C A C B ( ) % % % 3 3.0% 4 0.1% 1 0.3% % 0.3% SDS 0.1% 0.3% 0.3% SDS 0.1% 3.0% SDS 0.1% 3.0%

77 3.0% SDS A 1B

78

79 , , % > 0.3 % 0.1% > 3.0 %

80 : , , % % 3 Modified classification on?

81 GHS 3.9 GHS (a) 3.1 (b) 3.2 (c) 3.3 (d) 3.4 (e) 3.5 (f) 3.6 (g) 3.7 (f) ( ) ( ) (3.8.3)

82

83 (a) 1 (b) (a) (b) (c) (d) (e)

84 (f) (g) (a) (b) (c) (d) (e)

85 3.8.1 a 1 2 mg/kg C C 300 mg/kg C C 1000 Ppm C C 2500 mg/ C C 10 mg/ /4 C C 1.0 b a b mg kg 2000 mg kg

86 (a) (b) (RTI) (c) (d) (e) (a) (b)

87 Bridging principles (a) 2 ( ) A+B ( ) C+B (b) B (c) ( ) A ( ) C (d) A C B

88 ( ) % 10% 10% 1.0% 1.0% 10% % 10% SDS 1.0% 10% % SDS % 10% % 10% SDS

89 1.0% 10% % SDS % % 20%

90

91 % 10% > 1.0 < 10% % 10%

92

93 GHS 3.8 GHS

94

95 (a) (b) (a) (b) (c) (d) (e) (f) (g)

96 (a) (b) (c) (d) (e)

97 3.9.1 ( ) mg/kg / 10 mg/kg / 20 ppm/6 / 50 mg/l/6 / 0.2 mg/l/6 / ( ) mg/kg / mg/kg / ppm/6 / mg/l/6 / mg/l/6 / mg kg 100mg kg ( )

98 Bridging principle

99 A B C A B C A B (a) 2 ( ) A+B ( ) C+B (b) B (c) ( ) A ( ) C (d) A C A C B ( )

100 % % 1 1.0% 10% 3 1.0% 10% 3 1.0% 4 10% % 10% SDS 1.0% 10% % SDS % 10% % 10% SDS 1.0% 10% % SDS %

101

102

103 % 10% > 1.0 < 10% % 10%

104

105 Aspiration Aspiration Hazard (mpa s) / (g/cm 3 ) = (mm 2 /s)

106 (a) (b) mm 2 /s mm 2 /s Bridging Principles %

107 (a) (b) 2 ( ) A + B ( ) C + B ; (c) ( ) ( ) ; (d) ( ) ( ) % mm 2 /s % mm 2 /s % mm 2 /s

108 % mm 2 /s

109 mm 2 /s mm 2 /s

110 % mm 2 /s % 40 14mm 2 /s

http://www.who.int/ipcs/publications/ehc/en/index.html EHC 1 2 3 4 / EHC http://www.nihs.go.jp/dcbi/publist/ehchsg/ 1-8) WHO/IPCS CICAD (Concise Inter

http://www.who.int/ipcs/publications/ehc/en/index.html EHC 1 2 3 4 / EHC http://www.nihs.go.jp/dcbi/publist/ehchsg/ 1-8) WHO/IPCS CICAD (Concise Inter 3 [ ] Priority IARC JMPR 2004 10 Priority 1 Priority 1 Priority 2 Priority 3 Priority 1 1-1) CERI) http://www.cerij.or.jp/ceri_jp/koukai/sheet/sheet_indx4.htm http://www.safe.nite.go.jp/data/sougou/pk_list.html?table_name=hyoka&rank=sh

More information

44 4 I (1) ( ) (10 15 ) ( 17 ) ( 3 1 ) (2)

44 4 I (1) ( ) (10 15 ) ( 17 ) ( 3 1 ) (2) (1) I 44 II 45 III 47 IV 52 44 4 I (1) ( ) 1945 8 9 (10 15 ) ( 17 ) ( 3 1 ) (2) 45 II 1 (3) 511 ( 451 1 ) ( ) 365 1 2 512 1 2 365 1 2 363 2 ( ) 3 ( ) ( 451 2 ( 314 1 ) ( 339 1 4 ) 337 2 3 ) 363 (4) 46

More information

i ii i iii iv 1 3 3 10 14 17 17 18 22 23 28 29 31 36 37 39 40 43 48 59 70 75 75 77 90 95 102 107 109 110 118 125 128 130 132 134 48 43 43 51 52 61 61 64 62 124 70 58 3 10 17 29 78 82 85 102 95 109 iii

More information

14 12 10 8 6 4 2 0 1 2 3 4 5 6 7 8 9 10 11 12 20 0 0 0 0 0 0 0 0 0 0 0 0 21 0 0 0 0 0 0 0 0 0 0 0 0 22 0 0 0 0 0 0 0 0 0 0 0 0 23 0 0 0 0 0 0 0 0 0 0 0 0 24 0 0 0 0 0 0 0 0 0 0 0 0 25 0 0 0 0 0 0 0 0 0

More information

,309 t 22,069 t 7,240 t µg/l µg/l < ,431-70, , , mg/l m

,309 t 22,069 t 7,240 t µg/l µg/l < ,431-70, , , mg/l m 1 20019 1527 CAS 1317368 1230 PbO 223.20 1 99 1. 2 888 2 9.53 0.017 g/l 20 3 3 2 2. 10 29,309 t 22,069 t 7,240 t 4 1 3. 1 2 3.5 6 1 µg/l 9.1-24 2 µg/l < 43 6 27,431-70,000 4.5-1,300 13.4-17 31.7 0.48-3,459

More information

橡災害.PDF

橡災害.PDF 1 2 3 4 5 6 7 8 9 10 11 12 2.1 2.2 2.2.1 13 2.2.2 2.2.3 14 2.3 2.3.1 2.3.2 all or nothing 2.4. 2.4.1 15 i) ii) iii) iv) 2.5 2.4.2 2.2 2.5 2.5.1 16 2.5.2 2.6 2.6.1 2.4 2.6.2 2.6.3 2.6.4 17 18 3.2.1 Hazard

More information

i

i 14 i ii iii iv v vi 14 13 86 13 12 28 14 16 14 15 31 (1) 13 12 28 20 (2) (3) 2 (4) (5) 14 14 50 48 3 11 11 22 14 15 10 14 20 21 20 (1) 14 (2) 14 4 (3) (4) (5) 12 12 (6) 14 15 5 6 7 8 9 10 7

More information

- - - - - - - - - - - - - - - - - - - - - - - - - -1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -2...2...3...4...4...4...5...6...7...8...

- - - - - - - - - - - - - - - - - - - - - - - - - -1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -2...2...3...4...4...4...5...6...7...8... 取 扱 説 明 書 - - - - - - - - - - - - - - - - - - - - - - - - - -1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -2...2...3...4...4...4...5...6...7...8...9...11 - - - - - - - - - - - - - - - - -

More information

第1部 一般的コメント

第1部 一般的コメント (( 2000 11 24 2003 12 31 3122 94 2332 508 26 a () () i ii iii iv (i) (ii) (i) (ii) (iii) (iv) (a) (b)(c)(d) a) / (i) (ii) (iii) (iv) 1996 7 1996 12

More information

 

  10 44 1.2 5 4 5 3 6-1 - 1 2 3 4 5 1 2 3 4 5 6 7 8 1 2 3 4 5 6 7 8 9 10 TEL TEL 1 2 TEL FAX TEL FAX TEL FAX 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 1 2 3 4 5 6 ( ) ( ) 2

More information

1 (1) (2)

1 (1) (2) 1 2 (1) (2) (3) 3-78 - 1 (1) (2) - 79 - i) ii) iii) (3) (4) (5) (6) - 80 - (7) (8) (9) (10) 2 (1) (2) (3) (4) i) - 81 - ii) (a) (b) 3 (1) (2) - 82 - - 83 - - 84 - - 85 - - 86 - (1) (2) (3) (4) (5) (6)

More information

- 2 -

- 2 - - 2 - - 3 - (1) (2) (3) (1) - 4 - ~ - 5 - (2) - 6 - (1) (1) - 7 - - 8 - (i) (ii) (iii) (ii) (iii) (ii) 10 - 9 - (3) - 10 - (3) - 11 - - 12 - (1) - 13 - - 14 - (2) - 15 - - 16 - (3) - 17 - - 18 - (4) -

More information

2 1980 8 4 4 4 4 4 3 4 2 4 4 2 4 6 0 0 6 4 2 4 1 2 2 1 4 4 4 2 3 3 3 4 3 4 4 4 4 2 5 5 2 4 4 4 0 3 3 0 9 10 10 9 1 1

2 1980 8 4 4 4 4 4 3 4 2 4 4 2 4 6 0 0 6 4 2 4 1 2 2 1 4 4 4 2 3 3 3 4 3 4 4 4 4 2 5 5 2 4 4 4 0 3 3 0 9 10 10 9 1 1 1 1979 6 24 3 4 4 4 4 3 4 4 2 3 4 4 6 0 0 6 2 4 4 4 3 0 0 3 3 3 4 3 2 4 3? 4 3 4 3 4 4 4 4 3 3 4 4 4 4 2 1 1 2 15 4 4 15 0 1 2 1980 8 4 4 4 4 4 3 4 2 4 4 2 4 6 0 0 6 4 2 4 1 2 2 1 4 4 4 2 3 3 3 4 3 4 4

More information

...J......1803.QX

...J......1803.QX 5 7 9 11 13 15 17 19 21 23 45-1111 48-2314 1 I II 100,000 80,000 60,000 40,000 20,000 0 272,437 80,348 82,207 81,393 82,293 83,696 84,028 82,232 248,983 80,411 4,615 4,757 248,434 248,688 76,708 6,299

More information

第1章 国民年金における無年金

第1章 国民年金における無年金 1 2 3 4 ILO ILO 5 i ii 6 7 8 9 10 ( ) 3 2 ( ) 3 2 2 2 11 20 60 12 1 2 3 4 5 6 7 8 9 10 11 12 13 13 14 15 16 17 14 15 8 16 2003 1 17 18 iii 19 iv 20 21 22 23 24 25 ,,, 26 27 28 29 30 (1) (2) (3) 31 1 20

More information

表1票4.qx4

表1票4.qx4 iii iv v 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 22 23 10 11 24 25 26 27 10 56 28 11 29 30 12 13 14 15 16 17 18 19 2010 2111 22 23 2412 2513 14 31 17 32 18 33 19 34 20 35 21 36 24 37 25 38 2614

More information

ÿþ

ÿþ I O 01 II O III IV 02 II O 03 II O III IV III IV 04 II O III IV III IV 05 II O III IV 06 III O 07 III O 08 III 09 O III O 10 IV O 11 IV O 12 V O 13 V O 14 V O 15 O ( - ) ( - ) 16 本 校 志 望 の 理 由 入 学 後 の

More information

provider_020524_2.PDF

provider_020524_2.PDF 1 1 1 2 2 3 (1) 3 (2) 4 (3) 6 7 7 (1) 8 (2) 21 26 27 27 27 28 31 32 32 36 1 1 2 2 (1) 3 3 4 45 (2) 6 7 5 (3) 6 7 8 (1) ii iii iv 8 * 9 10 11 9 12 10 13 14 15 11 16 17 12 13 18 19 20 (2) 14 21 22 23 24

More information

untitled

untitled 1998 6 25 ( ) 1 10 1982 10 28 37/7 1990 12 14 45/94 (WHO) 1 1989 12 8 NGO (ECE) 3 1995 10 25 ECE 1991 2 25 1992 3 17 1998 6 4 1 2 1. 2. a b c (a) (b) d 17 3. a b (a) c (b) 4. 5. 3 1. 2. 3. 4. 5. 6. 7.

More information

「産業上利用することができる発明」の審査の運用指針(案)

「産業上利用することができる発明」の審査の運用指針(案) 1 1.... 2 1.1... 2 2.... 4 2.1... 4 3.... 6 4.... 6 1 1 29 1 29 1 1 1. 2 1 1.1 (1) (2) (3) 1 (4) 2 4 1 2 2 3 4 31 12 5 7 2.2 (5) ( a ) ( b ) 1 3 2 ( c ) (6) 2. 2.1 2.1 (1) 4 ( i ) ( ii ) ( iii ) ( iv)

More information

20 57

20 57 56 20 57 58 59 12 60 ph 61 62 CCA 63 64 ( 1) 700 7.5 86% 54 17 71 2) 700 6.8 86% 50 15 65 3) 600 700 5.7 84% 36 14 50 550 650 4.2 80% 21 6 27 40 500 3.6 78% 16 7 23 3.6 78% 16 7 23 400 700 4.0 78% 18 7

More information

i ii iii iv v vi vii ( ー ー ) ( ) ( ) ( ) ( ) ー ( ) ( ) ー ー ( ) ( ) ( ) ( ) ( ) 13 202 24122783 3622316 (1) (2) (3) (4) 2483 (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) 11 11 2483 13

More information

178 5 I 1 ( ) ( ) 10 3 13 3 1 8891 8 3023 6317 ( 10 1914 7152 ) 16 5 1 ( ) 6 13 3 13 3 8575 3896 8 1715 779 6 (1) 2 7 4 ( 2 ) 13 11 26 12 21 14 11 21

178 5 I 1 ( ) ( ) 10 3 13 3 1 8891 8 3023 6317 ( 10 1914 7152 ) 16 5 1 ( ) 6 13 3 13 3 8575 3896 8 1715 779 6 (1) 2 7 4 ( 2 ) 13 11 26 12 21 14 11 21 I 178 II 180 III ( ) 181 IV 183 V 185 VI 186 178 5 I 1 ( ) ( ) 10 3 13 3 1 8891 8 3023 6317 ( 10 1914 7152 ) 16 5 1 ( ) 6 13 3 13 3 8575 3896 8 1715 779 6 (1) 2 7 4 ( 2 ) 13 11 26 12 21 14 11 21 4 10 (

More information

cm H.11.3 P.13 2 3-106-

cm H.11.3 P.13 2 3-106- H11.3 H.11.3 P.4-105- cm H.11.3 P.13 2 3-106- 2 H.11.3 P.47 H.11.3 P.27 i vl1 vl2-107- 3 h vl l1 l2 1 2 0 ii H.11.3 P.49 2 iii i 2 vl1 vl2-108- H.11.3 P.50 ii 2 H.11.3 P.52 cm -109- H.11.3 P.44 S S H.11.3

More information

untitled

untitled 3 2) ( ) I ( ) 1) 16 ( : : ) 2) ( ) 1 ( ) 2 3 3 1. 2. 3. 4. ( ) 5. 6. TEACCH( ) TEACCH ( ) 10 ( ) 4 2 II 1) 1 2005 2 2004 2006 3 2003 12 1. 2. 3. 3 117 2006 4 ( ) 5 2) 1 2003 5 2 3) 1 ( ) 1998 2 3 4 NIPPON

More information

14 4 12 10 8 6 3 2 4 2 1 0 0 100200300400500600 100200300400500600700 0 0 100200300400500600 100200300400500600700 (ppm) (ppm) 7 4 6 5 4 3 3 2 2 1 1 0 0 100200300400500600 100200300400500600700 0 0 100200300400500600

More information

untitled

untitled i ii iii iv v 43 43 vi 43 vii T+1 T+2 1 viii 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 a) ( ) b) ( ) 51

More information

AccessflÌfl—−ÇŠš1

AccessflÌfl—−ÇŠš1 ACCESS ACCESS i ii ACCESS iii iv ACCESS v vi ACCESS CONTENTS ACCESS CONTENTS ACCESS 1 ACCESS 1 2 ACCESS 3 1 4 ACCESS 5 1 6 ACCESS 7 1 8 9 ACCESS 10 1 ACCESS 11 1 12 ACCESS 13 1 14 ACCESS 15 1 v 16 ACCESS

More information

BIT -2-

BIT -2- 2004.3.31 10 11 12-1- BIT -2- -3-256 258 932 524 585 -4- -5- A B A B AB A B A B C AB A B AB AB AB AB -6- -7- A B -8- -9- -10- mm -11- fax -12- -13- -14- -15- s58.10.1 1255 4.2 30.10-16- -17- -18- -19-6.12.10

More information

【知事入れ版】270804_鳥取県人口ビジョン素案

【知事入れ版】270804_鳥取県人口ビジョン素案 7 6 5 4 3 2 1 65 1564 14 192 193 194 195 196 197 198 199 2 21 22 23 24 1.65 1,4 1.6 1,2 1.55 1, 1.45 6 1.5 8 1.4 4 1.35 1.3 2 27 28 29 21 211 212 213 214 6 5 4 3 2 1 213 218 223 228 233 238 243 248 253

More information

2

2 1 2 3 4 5 6 7 8 9 10 I II III 11 IV 12 V 13 VI VII 14 VIII. 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 _ 33 _ 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 VII 51 52 53 54 55 56 57 58 59

More information

untitled

untitled ( ) 200133 3 3 3 3, 7 347 57 10 i ii iii -1- -2- -3- -4- 90011001700mm -5- 4.2 1991 73.5 44.4 7.4 10.5 10.5 7.4 W 3 H 2.25 H 2.25 7.4 51.8 140.6 88.8 268.8m 5,037.9m 2 2mm 16cm916cm 10.5 W 3 H 2.25 62.8

More information

Microsoft Word - SDS No.1-1

Microsoft Word - SDS No.1-1 1/10 安 全 データシート [SDS No. 1-1] 作 成 日 :1993 年 04 月 01 日 改 訂 日 :2016 年 07 月 01 日 1. 化 学 品 及 び 会 社 情 報 化 学 品 の 名 称 製 品 名 :エレファクスエッチ 液 エレファクス エッチ 液 会 社 情 報 会 社 名 : 岩 崎 通 信 機 株 式 会 社 担 当 部 署 : 第 一 営 業 本 部 第

More information

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 () - 1 - - 2 - - 3 - - 4 - - 5 - 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57

More information

1 10 200 15 20 50 (1) (2) 45 A4 JICA 15 WS 1 [] a. b. 10 A 30 15 15 NGO PC 5 15 15 15 15 NGO 1948 1970 10 NGO 90 AB 40 40 WS 1 NGO 40 WS Q 43 63 73 15 9 8 5 5 4 63 17 9 8 6 6 4 2000 14 15 100 2000 1

More information

Microsoft Word - 表紙資料2-4

Microsoft Word - 表紙資料2-4 (1) / 130 g 25 g 520% 170 g 30 g 560% 70 mg 600 mg 11.6% 0 10.5 mg 0% (1) (2) / 50100 g 25 g 200400% 50100 g 30 g 167333% 5001000 mg 600 mg 83167% 1020 mg 10.5 mg 95190% (2) / (1) 45.6 g 30 g 152% (2)

More information

ito.dvi

ito.dvi 1 2 1006 214 542 160 120 160 1 1916 49 1710 55 1716 1 2 1995 1 2 3 4 2 3 1950 1973 1969 1989 1 4 3 3.1 3.1.1 1989 2 3.1.2 214 542 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27

More information

86 7 I ( 13 ) II ( )

86 7 I ( 13 ) II ( ) 10 I 86 II 86 III 89 IV 92 V 2001 93 VI 95 86 7 I 2001 6 12 10 2001 ( 13 ) 10 66 2000 2001 4 100 1 3000 II 1988 1990 1991 ( ) 500 1994 2 87 1 1994 2 1000 1000 1000 2 1994 12 21 1000 700 5 800 ( 97 ) 1000

More information

入門ガイド

入門ガイド ii iii iv NEC Corporation 1998 v P A R 1 P A R 2 P A R 3 T T T vi P A R T 4 P A R T 5 P A R T 6 P A R T 7 vii 1P A R T 1 2 2 1 3 1 4 1 1 5 2 3 6 4 1 7 1 2 3 8 1 1 2 3 9 1 2 10 1 1 2 11 3 12 1 2 1 3 4 13

More information

SC-85X2取説

SC-85X2取説 I II III IV V VI .................. VII VIII IX X 1-1 1-2 1-3 1-4 ( ) 1-5 1-6 2-1 2-2 3-1 3-2 3-3 8 3-4 3-5 3-6 3-7 ) ) - - 3-8 3-9 4-1 4-2 4-3 4-4 4-5 4-6 5-1 5-2 5-3 5-4 5-5 5-6 5-7 5-8 5-9 5-10 5-11

More information

EPSON エプソンプリンタ共通 取扱説明書 ネットワーク編

EPSON エプソンプリンタ共通 取扱説明書 ネットワーク編 K L N K N N N N N N N N N N N N L A B C N N N A AB B C L D N N N N N L N N N A L B N N A B C N L N N N N L N A B C D N N A L N A L B C D N L N A L N B C N N D E F N K G H N A B C A L N N N N D D

More information

ありがとうございました

ありがとうございました - 1 - - 2 - - 3 - - 4 - - 5 - 1 2 AB C A B C - 6 - - 7 - - 8 - 10 1 3 1 10 400 8 9-9 - 2600 1 119 26.44 63 50 15 325.37 131.99 457.36-10 - 5 977 1688 1805 200 7 80-11 - - 12 - - 13 - - 14 - 2-1 - 15 -

More information

EPSON エプソンプリンタ共通 取扱説明書 ネットワーク編

EPSON エプソンプリンタ共通 取扱説明書 ネットワーク編 K L N K N N N N N N N N N N N N L A B C N N N A AB B C L D N N N N N L N N N A L B N N A B C N L N N N N L N A B C D N N A L N A L B C D N L N A L N B C N N D E F N K G H N A B C A L N N N N D D

More information

公務員人件費のシミュレーション分析

公務員人件費のシミュレーション分析 47 50 (a) (b) (c) (7) 11 10 2018 20 2028 16 17 18 19 20 21 22 20 90.1 9.9 20 87.2 12.8 2018 10 17 6.916.0 7.87.4 40.511.6 23 0.0% 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2.0% 4.0% 6.0% 8.0%

More information

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 A B (A/B) 1 1,185 17,801 6.66% 2 943 26,598 3.55% 3 3,779 112,231 3.37% 4 8,174 246,350 3.32% 5 671 22,775 2.95% 6 2,606 89,705 2.91% 7 738 25,700 2.87% 8 1,134

More information

橡hashik-f.PDF

橡hashik-f.PDF 1 1 1 11 12 13 2 2 21 22 3 3 3 4 4 8 22 10 23 10 11 11 24 12 12 13 25 14 15 16 18 19 20 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 144 142 140 140 29.7 70.0 0.7 22.1 16.4 13.6 9.3 5.0 2.9 0.0

More information

198

198 197 198 199 200 201 202 A B C D E F G H I J K L 203 204 205 A B 206 A B C D E F 207 208 209 210 211 212 213 214 215 A B 216 217 218 219 220 221 222 223 224 225 226 227 228 229 A B C D 230 231 232 233 A

More information

1

1 1 2 3 4 5 (2,433 ) 4,026 2710 243.3 2728 402.6 6 402.6 402.6 243.3 7 8 20.5 11.5 1.51 0.50.5 1.5 9 10 11 12 13 100 99 4 97 14 A AB A 12 14.615/100 1.096/1000 B B 1.096/1000 300 A1.5 B1.25 24 4,182,500

More information

ネットショップ・オーナー2 ユーザーマニュアル

ネットショップ・オーナー2  ユーザーマニュアル 1 1-1 1-2 1-3 1-4 1 1-5 2 2-1 A C 2-2 A 2 C D E F G H I 2-3 2-4 2 C D E E A 3 3-1 A 3 A A 3 3 3 3-2 3-3 3-4 3 C 4 4-1 A A 4 B B C D C D E F G 4 H I J K L 4-2 4 C D E B D C A C B D 4 E F B E C 4-3 4

More information

<4D6963726F736F667420506F776572506F696E74202D208376838C835B83938365815B835683878393312E707074205B8CDD8AB78382815B83685D>

<4D6963726F736F667420506F776572506F696E74202D208376838C835B83938365815B835683878393312E707074205B8CDD8AB78382815B83685D> i i vi ii iii iv v vi vii viii ix 2 3 4 5 6 7 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

More information

1 10 1113 14 1516 1719 20 21 22 2324 25 2627 i 2829 30 31 32 33 3437 38 3941 42 4344 4547 48 4950 5152 53 5455 ii 56 5758 59 6061 iii 1 2 3 4 5 6 7 8 9 10 PFI 30 20 10 PFI 11 12 13 14 15 10 11 16 (1) 17

More information

喘息について\(公健協会宛02-5作成\)

喘息について\(公健協会宛02-5作成\) Q & A Q & A 1.? 20 2. 1) 2) 3) 4) 5) 6) 7) 1) 2) 3) 4) 5) 6) 7) 8) 9) 3. NHK ( ) 4 10 1 200mg ( ) ( 1 ) 4. ( ) ( ) 5. ( ) ( ) 6. β 2 ( ) 7. ( ) 1 8. 1. 2. 3. 4. 5. 6. 7. 8. 9. 2 5 7 1. 1 10 1) 2) 3) 30

More information

untitled

untitled 23 12 10 12:55 ~ 18:45 KKR Tel0557-85-2000 FAX0557-85-6604 12:55~13:00 13:00~13:38 I 1) 13:00~13:12 2) 13:13~13:25 3) 13:26~13:38 13:39~14:17 II 4) 13:39~13:51 5) 13:52 ~ 14:04 6) 14:05 ~ 14:17 14:18 ~

More information

o 2o 3o 3 1. I o 3. 1o 2o 31. I 3o PDF Adobe Reader 4o 2 1o I 2o 3o 4o 5o 6o 7o 2197/ o 1o 1 1o

o 2o 3o 3 1. I o 3. 1o 2o 31. I 3o PDF Adobe Reader 4o 2 1o I 2o 3o 4o 5o 6o 7o 2197/ o 1o 1 1o 78 2 78... 2 22201011... 4... 9... 7... 29 1 1214 2 7 1 8 2 2 3 1 2 1o 2o 3o 3 1. I 1124 4o 3. 1o 2o 31. I 3o PDF Adobe Reader 4o 2 1o 72 1. I 2o 3o 4o 5o 6o 7o 2197/6 9. 9 8o 1o 1 1o 2o / 3o 4o 5o 6o

More information

ネオマファーム施工標準軸組構造

ネオマファーム施工標準軸組構造 注 1 注 2 注 2 SISI 1. 2. 30 35 40 50 15mm 303 (17kg/) 455 16mm, 18mm 250 (20kg/) 455 303 303 _ 6 455 650 10,465 910 2,730 1,820 1,820 910 2,275 1,365 415 450 650

More information

橡Taro11-報告書0.PDF

橡Taro11-報告書0.PDF Research Center RC 2001 5-1- RC RC NHK -2- -3- 00/12/16 RC 01/01/07 RC 01/01/21 1 13 01/02/11 2 9 01/02/10 01/02/14 01/02/19 01/02/25 3 7 01/03/10 4 8 01/03/23 5 8 01/04/29 2001/01/07-4- -5- RC 1990 RC

More information

3.ごみの減量方法.PDF

3.ごみの減量方法.PDF - 7 - - 8 - - 9 - - 10 - - 11 - - 12 - ( 100 ( 100 - 13-123,550,846 111,195,762 92,663,135 ( 12 25 37 49.2 16 33 49 65.6 15 30 44 59.0 2.5kg) ( 5kg) ( 7.5kg) ( k ( 123,550,846 111,195,762 92,663,135 (

More information

16 41 17 22 12 10

16 41 17 22 12 10 1914 11 1897 99 16 41 17 22 12 10 11 10 18 11 2618 12 22 28 15 1912 13 191516 2,930 1914 5,100 43 1.25 11 14 25 34364511 7.54 191420 434849 72 191536 1739 17 1918 1915 60 1913 70 10 10 10 99.5 1898 19034.17.6

More information

製品案内 価格表 2014/4/1

製品案内 価格表 2014/4/1 4 (17) 3 43 5/20370/ 231(504,150) 11 12 10 14-16 10 3 100 17 100kg 5-6 3 13 3 18 18 # # # # #$$ %&$ ' ()* +,-% ' #). +,-%'% / ' # # #$ %&&&'( %)* +'(#$ #$ %&&&'( ++,-). +'(#$ #$ /'( + /0)- +'(#$ %&&&'(

More information

4 13 6 7 6 13 9 19

4 13 6 7 6 13 9 19 13 9 4 13 6 7 6 13 9 19 139 173 i 1 1 2 1 3 2 4 2 5 1 3 6 4 7 5 8 6 9 6 Q&A Q1 QA 9 Q2 9 Q3 10 Q4 11 Q5 11 Q6 11 Q7 12 Q8 12 ii Q9 12 Q101 13 Q102 13 Q11 17 Q12 18 Q13 18 Q14 19 Q15 19 Q16 20 Q17 20 Q18

More information

EV200R I II III 1 2 3 4 5 6 7 8 9 10 1 2 3 11 4 5 12 6 13 1 2 14 3 4 15 5 16 1 2 17 3 18 4 5 19 6 20 21 22 123 456 123 456 23 1 2 24 3 4 25 5 3 26 4 5 6 27 7 8 9 28 29 30 31 32 1 2 33 3 4 34 1 35 2 1

More information

7... 1... 34... 55... 86... 108 15 2003 1 2 3 1 7 pdf 2 8 1996 2-1 9010 5 247 362 4 7 5 4 11 7 22 4 29 45 5 59 6 61 4 63 10 2 820 3 1646 19 1944 1 2 4 11 3 11 22 4 1 340 2 20 3 13 4 450 1 2 3 4 2-2 29

More information